Mylan Inc.

NASDAQ: MYL
The FDA is extending the expiration dates for certain EpiPens in light of the national shortage ahead of the back-to-school season.
Mylan has had a stranglehold on the market for EpiPen, but this is all changing after the FDA approved Teva for a generic version of it.
The top analyst upgrades, downgrades and other research calls from Monday included Akamai, Dollar Tree, Hasbro, Intel, Mylan, Netflix and Papa John's.
24/7 Wall St. tracked six companies that saw three or more analyst downgrades or price target cuts on Thursday, August 9, 2018.
The top analyst upgrades, downgrades and other research calls from Thursday include Applied Materials, Extreme Networks, Mylan, NXP, Roku, Seagate, Yelp and Zynga.
Mylan reported disappointing quarterly results before the markets opened on Wednesday, and shares retreated afterward.
24/7 Wall St. has put together a preview of Disney, Snap, CVS Health and some of the other companies that are about to report their quarterly results.
Adamis Pharmaceuticals saw its shares shoot up early on Monday after the firm announced a partnership with a subsidiary of Novartis.
Thursday was a positive day for the broad U.S. markets. Again, the Nasdaq hit an all-time high in the session reaching closer to 7,800. The S&P 500 is still holding just below the 2,800 mark....
Mylan saw its shares make a handy gain early on Tuesday after the FDA announced a key approval for Fulphila (pegfilgrastim-jmbd), a biosimilar to Neulasta (pegfilgrastim).
24/7 Wall St. has put together a preview of Disney, Nvidia, Valeant Pharmaceuticals and of some of the other top companies reporting their latest results in the coming week.
The top analyst upgrades, downgrades and other research calls from Thursday include Albermarle, American Airlines, Ellie Mae, Johnson & Johnson, Mallinckrodt, Mylan, NetApp and Southwest Airlines.
The top analyst upgrades, downgrades and other research calls from Thursday include AON, Broadcom, Expedia, Exxon Mobil, Match, Mylan, Ocean Rig UDW, Signet Jewelers and Transocean.
Mylan has been through the ringer over the past couple of years, but by the looks of it, this stock could be turning around.
The top analyst upgrades, downgrades and other research calls from Tuesday include Archer Daniels Midland, Cardlytics, Dermira, E*Trade, Herbalife, Mylan, UPS, VMware and Western Digital.